dihydroergotamine has been researched along with Chronic Disease in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (16.67) | 18.7374 |
| 1990's | 9 (50.00) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eller, M; Gelfand, AA; Goadsby, PJ; Riggins, NY; Schankin, C; Shiboski, S | 1 |
| Magnoux, E; Zlotnik, G | 1 |
| Charles, JA; Jotkowitz, S | 1 |
| Saper, JR; Silberstein, S | 1 |
| Azria, M; Chalas, J; Chaput, JC; Humbert, M; Labayle, D; Lavène, D; Lindenbaum, A | 1 |
| Kaiser, RS; Primavera, JP | 1 |
| Henn, V | 1 |
| Olive, D; Parisi, S; Walker, J | 1 |
| Cano, A; Roquer, J | 1 |
| Baskin, SM; Queiroz, LP; Rapoport, AM; Sheftell, FD; Siegel, SE; Weeks, RE | 1 |
| Kaplan, B; Swain, RA | 1 |
| Bøe, MG; Monstad, P | 1 |
| Prentice, A | 1 |
| Gupta, A; Rothner, AD | 1 |
| Silberstein, JR; Silberstein, SD | 1 |
| Hopkins, MM; Schulman, EA; Silberstein, SD | 1 |
| Beck, B; Daniel, H | 1 |
| Raskin, NH | 1 |
4 review(s) available for dihydroergotamine and Chronic Disease
| Article | Year |
|---|---|
Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine.
Topics: Analgesics, Non-Narcotic; Chronic Disease; Dihydroergotamine; Humans; Migraine Disorders | 2006 |
Diagnosis, prophylaxis, and treatment of headaches in the athlete.
Topics: Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Chronic Disease; Cluster Headache; Dihydroergotamine; Female; GABA Agents; Headache; Humans; Male; Migraine Disorders; Nortriptyline; Physical Exertion; Psychomotor Performance; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sports; Sumatriptan; Tension-Type Headache; Valproic Acid; Vasodilator Agents; Verapamil | 1997 |
Medical management of chronic pelvic pain.
Topics: Antidepressive Agents; Chronic Disease; Dihydroergotamine; Female; Humans; Medroxyprogesterone Acetate; Pelvic Pain; Pelvis; Progesterone Congeners; Varicose Veins; Vasoconstrictor Agents | 2000 |
Treatment of childhood headaches.
Topics: Acute Disease; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Chronic Disease; Clinical Trials as Topic; Dihydroergotamine; Dopamine Antagonists; Double-Blind Method; Headache; Humans; Infant; Meninges; Migraine Disorders; Models, Theoretical; Patient Care Management; Prostaglandin Antagonists; Randomized Controlled Trials as Topic; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Tension-Type Headache; Trigeminal Nerve; Vasoconstrictor Agents | 2001 |
2 trial(s) available for dihydroergotamine and Chronic Disease
| Article | Year |
|---|---|
Observations of the "carry-over effect" following successful termination of chronic migraine in the adolescent with short-term dihydroergotamine, dexamethasone and hydroxyzine: a pilot study.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Anti-Inflammatory Agents; Brain; Chronic Disease; Dexamethasone; Dihydroergotamine; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Headache Disorders; Histamine H1 Antagonists; Humans; Hydroxyzine; Infusions, Parenteral; Male; Migraine Disorders; Pilot Projects; Treatment Outcome; Vasoconstrictor Agents | 2005 |
Repetitive intravenous dihydroergotamine as therapy for intractable migraine.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Diazepam; Dihydroergotamine; Female; Humans; Injections; Injections, Intravenous; Male; Middle Aged; Migraine Disorders; Suppositories; Time Factors | 1986 |
12 other study(ies) available for dihydroergotamine and Chronic Disease
| Article | Year |
|---|---|
Exacerbation of headache during dihydroergotamine for chronic migraine does not alter outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; California; Causality; Chronic Disease; Comorbidity; Dihydroergotamine; Female; Headache; Humans; Incidence; Injections, Intravenous; Male; Middle Aged; Migraine Disorders; Retrospective Studies; Risk Factors; Treatment Outcome; Vasoconstrictor Agents; Young Adult | 2016 |
Outpatient intravenous dihydroergotamine for refractory cluster headache.
Topics: Adult; Aged; Ambulatory Care; Analgesics, Non-Narcotic; Chronic Disease; Cluster Headache; Dihydroergotamine; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Verapamil | 2004 |
[Pharmacokinetics of dihydroergotamine in patients with chronic liver disease (author's transl)].
Topics: Adult; Aged; Chronic Disease; Dihydroergotamine; Humans; Kinetics; Liver Cirrhosis, Alcoholic; Liver Diseases; Middle Aged | 1982 |
The relationship between locus of control, amount of pre-admission analgesic/ergot overuse, and length of stay for patients admitted for inpatient treatment of chronic headache.
Topics: Attitude to Health; Chronic Disease; Dihydroergotamine; Headache; Humans; Internal-External Control; Length of Stay; Substance-Related Disorders | 1994 |
[The treatment of chronic headache].
Topics: Adrenergic beta-Antagonists; Analgesics; Calcium Channel Blockers; Chronic Disease; Combined Modality Therapy; Dihydroergotamine; Electroencephalography; Female; Headache; Humans; Magnetic Resonance Imaging; Male; Spinal Puncture; Substance-Related Disorders; Tomography, X-Ray Computed | 1993 |
Analgesic rebound headache: experience in a community hospital.
Topics: Adult; Analgesics; Chronic Disease; Dihydroergotamine; Female; Headache; Hospitals, Community; Humans; Hypnotics and Sedatives; Male; Retrospective Studies; Substance Withdrawal Syndrome | 1993 |
[Ambulatory care of chronic headache secondary to abuse of ergot preparations].
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dihydroergotamine; Ergot Alkaloids; Female; Flunarizine; Headache; Humans; Male; Middle Aged; Naproxen; Prospective Studies; Substance-Related Disorders; Time Factors; Vasodilator Agents | 1996 |
Early and transient side effects of repetitive intravenous dihydroergotamine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Chronic Disease; Dihydroergotamine; Female; Headache; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Prospective Studies | 1996 |
[Transformed migraine--chronic daily headache].
Topics: Adult; Analgesics, Non-Narcotic; Chronic Disease; Dihydroergotamine; Female; Headache; Humans; Injections, Intravenous; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Terminology as Topic; Treatment Outcome; Vasoconstrictor Agents | 1999 |
Chronic daily headache: long-term prognosis following inpatient treatment with repetitive IV DHE.
Topics: Adult; Aged; Chronic Disease; Dihydroergotamine; Drug Administration Schedule; Female; Follow-Up Studies; Headache; Hospitalization; Humans; Injections, Intravenous; Interviews as Topic; Male; Middle Aged; Prognosis; Substance-Related Disorders; Time Factors | 1992 |
Repetitive intravenous DHE in the treatment of refractory headache.
Topics: Chronic Disease; Cluster Headache; Dihydroergotamine; Headache; Humans; Injections, Intravenous; Nausea; Retrospective Studies | 1990 |
[Ergotismus as a consequence of migraine prevention].
Topics: Adult; Chronic Disease; Dihydroergotamine; Ergotism; Female; Femoral Artery; Heparin; Humans; Ischemia; Leg; Migraine Disorders; Popliteal Artery; Thromboembolism | 1987 |